These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 35416564)
1. Inflammatory bowel disease and carcinogenesis. Nagao-Kitamoto H; Kitamoto S; Kamada N Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564 [TBL] [Abstract][Full Text] [Related]
2. Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology. Yin Y; Wan J; Yu J; Wu K Inflamm Bowel Dis; 2023 Oct; 29(10):1648-1657. PubMed ID: 37202830 [TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of colitis-associated colorectal cancer. Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533 [TBL] [Abstract][Full Text] [Related]
4. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives. Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120 [TBL] [Abstract][Full Text] [Related]
5. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma. Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862 [TBL] [Abstract][Full Text] [Related]
6. Vitamin-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis. Zhai Z; Dong W; Sun Y; Gu Y; Ma J; Wang B; Cao H Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014889 [TBL] [Abstract][Full Text] [Related]
8. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Fantini MC; Guadagni I Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939 [TBL] [Abstract][Full Text] [Related]
10. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection. Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769 [TBL] [Abstract][Full Text] [Related]
11. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Kang M; Martin A Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070 [TBL] [Abstract][Full Text] [Related]
12. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781 [TBL] [Abstract][Full Text] [Related]
13. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach. Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190 [TBL] [Abstract][Full Text] [Related]
14. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Breynaert C; Vermeire S; Rutgeerts P; Van Assche G Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276 [TBL] [Abstract][Full Text] [Related]
15. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer. Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380 [TBL] [Abstract][Full Text] [Related]
16. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice. Xu YL; Ding CL; Qian CL; Qi ZT; Wang W Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898 [TBL] [Abstract][Full Text] [Related]
17. ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer. Shi R; Wang S; Jiang Y; Zhong G; Li M; Sun Y Front Endocrinol (Lausanne); 2024; 15():1348216. PubMed ID: 38516408 [TBL] [Abstract][Full Text] [Related]
18. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies. Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs, intestinal inflammatory and tumor. Feng Y; Zhang Y; Zhou D; Chen G; Li N Bioorg Med Chem Lett; 2019 Aug; 29(16):2051-2058. PubMed ID: 31213403 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer. Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]